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ABSTRACT 
 
Purpose: To compare the reliability of rebound tonometry (RT) with that of Goldmann 
applanation tonometry (GAT) in patients with corneal scars. 
Methods: Three measurements were taken with each instrument. Instruments were 
compared by determining the differences between repeat measurements, by using a non-
parametric ANOVA on repeat measurements and by calculating the coefficient of 
repeatability (CR). A control group with normal corneas were examined to establish 
baseline correlation, repeatability and observer proficiency. 
Results: 61 eyes of 48 patients were included in the group with scarred corneas. The CR of 
RT was 2.667. The CR of GAT was 4.819. RT was more reliable than GAT in patients 
with corneal scars. The correlation coefficient of RT with GAT was 0.8959. 
Conclusion: RT correlated well with GAT in both scarred and control subjects. RT was 
more reliable than GAT in patients with corneal scars. GAT was more reliable than RT in 
control patients. 
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1 INTRODUCTION 
 
 
1.1 Background 
 
Glaucoma is the leading cause of irreversible blindness in not only Africa, but also the 
world. It is second only to cataract among all visual disorders that lead to blindness.1,2 
Africa has the highest ratio of glaucoma patients to adult population.2 This is due to a 
higher prevalence in the elderly compared to other countries, and not due to 
proportionately more older people, as is the case in certain European and Asian regions.  
 
In Southern Africa, glaucoma has been shown to be a significant health problem in both 
rural and urban populations, with reports consisting of two major indigenous ethnic groups. 
Glaucoma has been estimated to be the major aetiologic factor in 20-32% of all blind 
patients, with primary open angle glaucoma (POAG) and pseudoexfoliative glaucoma 
being the most common subtypes. It has also been shown that the majority of glaucoma 
patients in this subgroup are still undiagnosed and untreated.3,4 Glaucoma in Africans may 
occur at a younger age, may be associated with higher intraocular pressure (IOP) and more 
rapid progression, and patients may present with advanced or end-stage disease.5 
 
Glaucoma is a heterogenous group of disorders with a multifactorial pathogenesis, 
including raised intraocular pressure and vascular dysregulation. IOP has been shown to 
play an important role in retinal ganglion cell apoptosis and changes in extracellular matrix 
components at the optic nerve head, leading to the characteristic clinical appearance 
associated with glaucoma.6 Despite the IOP being normal in some subtypes of glaucoma, 
IOP continues to be a major risk factor for the development and progression of 
glaucomatous optic nerve damage.7,8 IOP is also an important measurable parameter and 
the main target of current glaucoma treatment modalities. Medical and surgical 
interventions that lower IOP have been shown to prevent the progression of glaucomatous 
damage in primary open angle glaucoma (POAG) as well as preventing or delaying the 
onset of POAG in ocular hypertensive patients.9,10,11,12 Accurate measurement of IOP 
therefore remains an important objective in the management of glaucoma patients. 
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The Goldmann applanation tonometer (GAT) is widely accepted as the gold standard for 
measuring intraocular pressure. However, the accuracy of applanation tonometry has come 
into question, with many limitations being proven clinically and through theoretical 
mathematics. Different corneal pathologies in particular have been shown to cause either 
overestimation or underestimation of IOP readings.13,14,15,16,17,18 Corneal pathology is often 
an exclusion criterion in studies aiming to describe or compare IOP measuring 
devices.19,20,21,22,23,24,25,26,27,28,29,30 However, glaucoma itself, as well as pressure lowering 
procedures, can be associated with or responsible for various corneal abnormalities, 
especially corneal scars and oedema or bullae. Subsequent infection, thinning, scarring and 
vascularization may be the result.14,31,32,33  On the other hand, some diseases and 
procedures associated with corneal or more widespread anterior segment pathology are 
also associated with raised intraocular pressures and glaucoma, such as herpetic eye 
disease, trauma, penetrating keratoplasty (PKP), and the anterior segment 
dysgeneses.18,26,34,35,36,37,38,39 Accurate estimations of IOP are therefore an important aspect 
of adequately managing patients with corneal abnormalities, but are often not possible in 
these patients due to the inherent limitations of applanation tonometry. (See Table 1.1.) 
 
Rebound tonometry (RT) is an established, albeit relatively new means of measuring IOP. 
RT measurements have been shown to correlate well with Goldmann applanation 
tonometry.18,19,21,27,29,30,40,41,42,43,44 It has been postulated that the small contact surface of 
the rebound tonometer’s probe gives it an advantage over GAT in patients with corneal 
pathology, and RT has been shown to correlate better with manometric IOP than GAT in 
eye with severely oedematous corneas.14,18,42,43,44 It has also been shown that RT is easier 
to use by less experienced individuals and might therefore be the ideal tool for screening 
programs.21,28  
 
Until recently, the Tono-Pen XL has been an accepted substitute for IOP measurement in 
patients with corneal pathologies that make GAT difficult or impossible. It is, however, not 
without limitations and it is not universally accepted as a sufficiently accurate instrument.  
26,42,45,46,47 The search is still on for an instrument that is more reliable and user-friendly in 
this subgroup of patients. 
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1.2 Literature Review 
 
1.2.1 Goldmann applanation tonometry  
 
A description of the dynamic relationship between the ocular aqueous humour, the ocular 
wall and the intraocular pressure is beyond the scope of this literature review. The 
importance of measuring the intraocular pressure (IOP) accurately is explained in the 
introduction above. Goldmann applanation tonometry (GAT) was described in 1954.48 It 
was to serve as another contender in the search for the ideal tonometer.  
 
Applanation tonometry is based on the Imbert-Fick law which states that, the pressure 
inside a perfect, dry, thin-walled sphere equals the force necessary to flatten an area of its 
surface divided by the area of flattening,13 
 
P = F/A where P = pressure 
   F = force 
   A = area 
 
In applanation tonometry, the globe represents a less-than-perfect sphere, flattening occurs 
at the cornea with its variable thickness and rigidity, and the wall of the sphere is not dry, 
but covered with a tear film. 
 
In 1957, shortly after the introduction of GAT, Perkins gave an outline of the 
characteristics of the ideal tonometer, stating that it needed to: 
- produce small distortion of the globe 
- be light weight 
- cause low reading error 
- be mechanically stable 
- be non-traumatic 
- be easy to use, and 
- easy to sterilize.49 
 
Perkins questioned whether the theory upon which applanation tonometry was based was 
universally applicable and suggested that “certain other factors were concerned.”  He 
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nonetheless referred to Goldmann’s design as “ingenious” and suggested that more work 
needed to be done.49  
 
Less than twenty years later, Goldmann applanation tonometry was known as “the most 
accurate and reproducible measure of intraocular pressure...representing the standard.” In 
fact, it was Perkins himself who eventually developed a portable applanation tonometer 
based on the same optical principles used by Goldmann – the Perkins applanation 
tonometer (PAT).17,50 PAT would later be described to be “of unquestioned excellence”, 
notwithstanding the fact that their use in patients with corneal pathology remained 
limited.51 
 
Since then, however, the effect of not only corneal abnormalities, but also normal corneal 
parameters, on GAT readings have been studied and reviewed extensively, increasingly 
bringing into question the accuracy of what has been the gold standard for roughly half a 
century. 13,14,15,16,17,51 Corneal properties that are known to cause an overestimation of IOP 
with GAT include steep curvature and against-the-rule astigmatism, mild epithelial 
oedema, increased stromal thickness, and increased rigidity, which might be normal or due 
to stromal scarring. Corneal characteristics opposite to these, are likely to cause an 
underestimation of IOP. Table 1.1 provides a summary of corneal findings and the likely 
effect on GAT readings taken in these patients. 
 
Despite the known difficulties, Goldmann applanation tonometry is the most widespread 
tonometer in clinical use, not only in normal, but also abnormal corneas. Although in 
question, it is still considered by some to be clinically relevant in patients that have 
previously undergone corneal surgery. In the place of true, manometric IOP measurement, 
new instruments are clinically correlated with GAT, and there are numerous examples of 
these correlations being done in patients with corneal pathology.18,26,34,43,44 In our opinion, 
one problem with these correlation studies is that their primary endpoints are usually the 
IOP values and differences thereof between instruments, and this in a setting where it is 
known that the gold standard is unreliable. Instead, or at least in addition, one should look 
at the reliability of each instrument in each clinical setting to decide which is most 
appropriate. 
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Table 1.1 – Sources of error during Goldmann applanation tonometry.13,14,15,17,42,51 
Corneal Finding       Effect on GAT IOP estimation 
 Curvature: 
Steeper 
Flatter 
 
Regular astigmatism – with the rule 
                                  – against the rule 
 
Irregular astigmatism 
 
 
Overestimated 
Underestimated 
 
Underestimated 
Overestimated 
 
Unreproducible, high variability 
 Epithelium: 
Oedema – mild (<40μm) 
             – more severe 
 
Scarring 
 
 
Overestimated 
Underestimated (“Soft” cornea) 
 
Difficult endpoint (unreproducible) 
 Stroma: 
Rigidity (corneoscleral) – higher 
 
Thin (CCT, e.g. Keratoconus) 
Thickened (CCT, non-oedematous) 
 
 
Oedema 
 
Scarring 
– May cause increased rigidity 
– Post LASIK 
 
Immune / Crystalline deposits 
 
 
Overestimated 
 
Underestimated 
Overestimated 
(Underestimates effect of rigidity) 
 
Underestimated 
 
Difficult endpoint (unreproducible) 
– Overestimated 
– Underestimated, increased variability 
 
Unknown 
 
 Position – decentred probe Minimal 
6 
 
There is therefore still need for a tonometer that is less dependent on the corneal properties 
than the Goldmann applanation tonometer or one that is capable of reliably compensating 
for these confounding variables. It is also clear that the greatest difficulty in obtaining 
accurate, repeatable measurements (an “endpoint” with minimal deviation in a given 
individual at a given time) is caused by irregularities in any one of the above corneal 
variables, be it curvature, surface, or rigidity and distribution of connective tissue types 
(scar tissue vs normal). The ideal tonometer would be minimally affected by these 
irregularities or capable of repeatedly obtaining measurements from corneal areas deemed 
least abnormal, whilst avoiding contact with areas that would negatively affect the 
repeatability of readings. In addition, due to the global burden of glaucoma, and due to  
Africans being disproportionately affected by the disease, the ideal tonometer should be 
relatively easy and affordable to use and maintain by healthcare professionals working 
across the spectrum of rural screening clinics to academic institutions. 
 
1.2.2 The Tono-Pen XL 
 
Instruments that involve contact or interaction with only small and, if needed, peripheral 
areas of the cornea, are considered by some to be more reliable than GAT in patients with 
scarred, oedematous or irregular corneas.14,26,42,43,44 The Tono-Pen is a small, hand-held, 
contact tonometer that works on principles shared by the GAT and MacKay-Marg 
electronic applanation tonometers. Newer versions, such as the Tono-Pen XL (TPXL), 
have improved software for faster measurement speeds. The Tono-Pen XL has an 
applanation area of 2.36mm2 and is thought to be less affected by CCT and ocular surface 
abnormalities. It correlates well with GAT and manometric IOP measurements when used 
on eyes with normal corneas.47 
 
It is of important to take multiple measurements with the Tono-Pen XL and use the built in 
standard deviation (SD) calculator to determine whether measurements are acceptable. For 
this reason, and due to the fact that frequent recalibrations are needed, it is considered to be 
slightly less user-friendly than GAT. Casting further doubt on its overall accuracy, the 
Tono-Pen XL has also been shown to correlate less well with GAT when the IOP is outside 
the normal range, and as with GAT its measurements might be affected by central corneal 
thickness, corneal rigidity and corneal deposits.44,46,47 
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The Tono-Pen  is, however, used widely in clinical practice for IOP measurements in eyes 
that have had previous PKP and has also been shown to be more accurate than GAT in 
severely oedematous corneas. 26,42 It is therefore currently the chosen instrument to use on 
eyes of which corneal irregularities make GAT impossible. 
 
1.2.3 Rebound Tonometry – The ICare 
 
The rebound tonometer concept was described by Kontiola in 1997.52 The principle on 
which it is based was described by Dekking & Coster in 1967.19 It is a recent addition to 
the existing arsenal of instruments that estimate intraocular pressure. The system comprises 
a solenoid, a magnetised probe and analysing electronics. The probe is 25-40mm long, 
0.3mm in diameter with a 1.0-1.7mm diameter round, plastic tip, and weighs 26.5g. The 
probe is placed within the solenoid and the tonometer is held as such that the tip of the 
probe is 4-8mm from the eye, perpendicular to the corneal surface. The probe is then 
electromagnetically propelled towards the cornea by the solenoid at a velocity of 
approximately 0.2 meters per second. As the probe impacts the cornea, it decelerates 
rapidly before bouncing back from the corneal surface. The inverse of the probe’s 
deceleration time was shown to correlate well with manometric IOP. Built-in analysing 
software uses this measured rate of deceleration from the time of impact to calculate the 
intraocular pressure.29,40 Other key features of RT are that it is small, portable and hand-
held, it has a very small contact surface, it does not require the use of topical anaesthetic, 
and its use causes minimal patient discomfort.16,30 
 
The clinical use of RT (ICare Finland, Helsinki, Finland) and its correlation with 
Goldmann-type applanation tonometry has been well documented. However, most of the 
studies done, exclude patients with existing corneal pathology. 19,20,21,22,23,24,25,27,28,29,30 The 
most common finding is a good correlation between rebound tonometry and applanation 
tonometry.19,21,23,27,28,30,34,40,41 Mean rebound tonometry values tend to be higher than 
applanation tonometry, although the difference is often less than 1mmHg and statistically 
insignificant. There is also very little difference between the standard deviations of each 
method within each study population. A higher discrepancy between the two instruments 
have been reported, although even then it is often less than 2mmHg, which is considered a 
clinically significant cut-off. 22,23,24,25,29,53,54,55 The greatest differences were in a known 
congenital glaucoma paediatric population and in oedematous grafts following penetrating 
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keratoplasty. Few reports show rebound tonometry underestimating the IOP compared to 
applanation tonometry (AT).21,55 
 
IOPs outside the normal range are associated with a reduction in the agreement between 
the two instruments, although, this does not always reach statistical significance. There 
tends to be a greater overestimation of IOP by RT in patients with IOPs above 
21mmHg.23,25,29,30 
 
Cannulising the anterior chamber and then correlating instrument measurements with true 
(manometric) IOP, is the only way to really determine which instrument is most accurate 
and reliable. However, this is not a practically feasible or ethical in vivo model for use in 
human subjects.25,42 In one study on oedematous, thickened corneas (CCT 616-627) 
mounted on an artificial anterior chamber, the manometric IOP could be used as reference 
standard.42 In this study RT was shown to be more reliable across a wide range of IOPs 
(10-50mmHg) than both GAT and the Tono-Pen XL. GAT measured consistently lower 
than manometry, except at 10mmHg. RT was consistently within 2mmHg of the 
manometric value, except at 10mmHg. This shows that agreement with the gold standard 
(GAT in this case) in terms of values obtained is not the only measure of an instrument’s 
accuracy. The standard deviation for RT was also lower across the entire range of IOPs. 
 
Rebound tonometry is considered easy to use and sufficiently accurate even by health care 
workers lacking ophthalmic experience.21,41,43 RT is also reported to be more comfortable 
in adult patients, even without topical anaesthetic, and reduces the need for general 
anaesthetic in paediatric populations.24,27,30,56 Some advantages of RT are listed in table 1.2 
below, with the Goldmann-type tonometers (GAT and PAT) shown for comparison. 
 
RT Sources of error: Most authors report a decreasing correlation between RT and GAT 
as the measured IOP value increases.23,29 This was, however, not always found to be the 
case.27,30,41 Factors that affect corneal rigidity, especially central corneal thickness (CCT), 
influence not only GAT readings, but also those taken with RT. Increased CCT is 
associated with increased IOP values with RT. Some authors found this correlation to be 
similar to the relationship between GAT and CCT, not leading to a reduced agreement 
between the two instruments,16,29,41,54 while others found a decreased correlation of RT  
with GAT as CCT increased.22,23,24,27 It has also been reported that CCT had minimal effect 
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Table 1.2 – Advantages of rebound tonometry compared to GAT16,23,29,30,41,42,56 
 
Rebound Tonometry:    GAT / PAT:  
 
- Portable       - PAT only 
- Position independent  (ICare Pro only)  - PAT only 
- No anaesthetic, more tolerable   - Intolerable without anaesthetic 
       - Adults: Topical 
       - Paediatric: Topical / GA 
- Tear film – no effect     - Significant effect readings 
- No fluorescein needed    - More difficult without  
- Small contact surface    - Larger contact area required 
- Indicates unreliable reading automatically  - User dependant 
- Objective digital reading.     - Analogue scale on most GAT / 
PAT 
- Possibly less effect with repeated readings  - Repeats reduce IOP 
- Brief contact - Possibly reduced risk  - Longer contact time 
- Easy to use, possibly shorted learning curve - Possibly requires more experience 
 
 
 
on IOP readings. It is postulated that RT is affected more by inherent biomechanical 
properties of the cornea than simply the thickness thereof.41,55 Taking RT readings directly 
from an area with corneal pathology, causes increased variability.44 
 
Other disadvantages of RT: It is currently advocated that a new probe be used for each 
patient.20 This might lead to increased cost of consumables with RT as compared to GAT, 
the latter in which it is common practice to clean the contact surface with a 70% alcohol 
swab.17 In the event that RT probes are re-used, it is the author’s experience that the 
delicate probes are difficult to clean. 
 
Repeatability and RT: Repeatability of measurements is a way of describing variation in 
repeat measurements made on the same subject under identical conditions, that is, by the 
same observer (intra-observer), using the same instrument and with minimal time elapsing 
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between measurements. Variability in measurements made under these conditions 
(immediate test-retest) is ascribed to errors due to the measurement method itself, and are 
used to quantify the reliability of measurements made by that particular method.29,57 
 
RT shows good baseline repeatability. Intra-observer correlation coefficients of 0.73-0.87 
have been reported.29 Measurements were hardly affected by distance from the cornea (3-
5mm) or angle of incidence of the probe onto the cornea. Patients with higher-than-normal 
pressures were included. Mean CCT was 544.58μm. Corneal pathology was excluded. As 
described above, corneal pathology is known to reduce repeatability (or increase 
variability) of multiple measurements done by GAT. It is the purpose of this study to 
evaluate the repeatability of RT in this specific subgroup of patients and compare it with 
GAT (or with the Tono-Pen XL in eyes that don’t allow GAT). With RT, IOP 
measurements taken from paracentral areas of the cornea correlated well with central 
measurements, with slight underestimation of mean values when measuring paracentrally 
(0.3-1.9mmHg).20,55 This compares well with the “no large change” reported in the 
literature for paracentral measurements taken with GAT.13 
 
Rebound tonometry has been shown to be less repeatable than GAT when IOPs were 
measured two weeks apart.40 It is not clear what the difference in repeatability is between 
RT and GAT when multiple measurements are taken on patients at a given point in time, 
i.e. with relatively little time elapsing between measurements. One study also reported 
good interobserver reproducibility of RT, not comparing it with GAT at the same time.29 
 
 
1.3 Rationale (Introduction Summary) 
- Glaucoma is currently an African and global health problem, being the leading cause of 
irreversible blindness and overall the second most common cause of visual disability. 
- Intraocular pressure is a major risk factor in the pathogenesis of glaucoma. 
- Corneal pathology and glaucoma are commonly found concurrently in a patient and can 
be associated with each other in various ways. 
- Corneal pathology is a known risk factor for unreliable estimates of intraocular pressure. 
The negative effect of corneal pathology on the accuracy of the gold standard instrument, 
Goldmann applanation tonometry, is well documented. 
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- Corneal pathology is often excluded when instruments for IOP measurement are 
compared. 
- Tonometers with small contact surfaces have been shown to be more reliable in patients 
with corneal pathology. The rebound tonometer is a new instrument that requires a small 
contact surface for IOP measurement. 
- Rebound tonometry correlates well with Goldmann applanation tonometry. 
- Intra-observer test-retest repeatability is an accepted method for assessing the reliability 
of measurement instruments. 
 
 
1.4 Purpose, Objectives and Hypothesis of the Study 
 
The purpose of this study was to compare the reliability of the rebound tonometer with the 
reliability of the gold standard, the Goldmann applanation tonometer, in patients with a 
specific corneal pathology, namely corneal scars. This was done by determining the 
repeatability of rebound tonometry (RT) in patients with corneal pathology, and then 
comparing it with the repeatability of Goldmann applanation tonometry (GAT) in the same 
group of patients. 
 
Where Goldmann applanation tonometry was not possible due to extreme abnormalities, 
the rebound tonometer would be compared in the same way to the Tono-Pen XL. 
 
We hypothesized that the repeatability of readings taken with the rebound tonometer would 
be greater than those taken with GAT in patients with corneal scars, because the small 
contact surface of the rebound tonometer would allow for measurements to be taken at a 
clinically pre-selected area of the cornea that was least affected by the scarring. 
Measurements with the rebound tonometer would therefore be less affected by the corneal 
scarring and the resulting changes in corneal thickness, rigidity and surface regularity.  
 
The correlation between mean IOP values obtained with each instrument was determined.  
 
RT was also compared to GAT in a control group of patients with normal corneas to assess 
baseline repeatability and correlation of the instruments in the current setting and to 
demonstrate observer proficiency with the instruments.  
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2 METHODS 
 
 
2.1 Study Design 
 
The overall design was that of a controlled, comparative study. The methods being 
compared were two different instruments used for measuring intraocular pressure, namely 
the gold standard Goldmann applanation tonometer (GAT) and the rebound tonometer 
(RT). The methods were compared on the basis of their repeatability in patients with 
corneal scars; essentially, two repeatability studies were done on the same population at the 
same time by the same observer – one with each instrument. The results of the instruments 
were compared.  
 
Instruments were also correlated in terms of their mean values measured. 
 
The same comparison was done in a control population to determine the baseline 
repeatability and correlation of the instruments and to show observer proficiency in the 
current context. 
 
Primary Objective: 
- To determine the repeatability of rebound tonometry in a study population of patients  
   with corneal scars. 
- To determine the repeatability of Goldmann applanation tonometry in the same study  
   population. 
- To compare the repeatability of rebound tonometry with that of Goldmann applanation  
   tonometry in the study population in order to determine which instrument is more  
   reliable in the setting of corneal scarring. 
 
Secondary Objectives: 
- To determine the repeatability of rebound tonometry in a control group of patients  
   with normal corneas 
- To determine the repeatability of Goldmann applanation tonometry in the same control  
   group. 
- To compare the repeatability of rebound tonometry with that of Goldmann applanation  
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   tonometry in the control group in order to determine which instrument is more  
   reliable in patients with normal corneas. 
- To determine the correlation between mean IOP values obtained with each instrument in  
   each group. 
 
 
2.2 Approval 
 
The study protocol was approved by the Human Research Ethics Committee (Medical) of 
the University of the Witwatersrand (Reference: M150729) and by the Research Protocol 
Assessor Group of the University of the Witwatersrand, Department of Neurosciences.  
The study adheres to the principles set out in the Declaration of Helsinki. The observer has 
no financial or conflicting interests to declare. 
 
 
2.3 Site of Data Collection 
 
The study took place at the St John Eye Hospital (SJEH) – Ophthalmology department of 
the Chris Hani Baragwanath Academic Hospital in Soweto, Johannesburg, South Africa. 
 
 
2.4 Study population 
 
Patients seen for routine visits at SJEH during the study period and that met the inclusion 
criteria were examined for the study purposes. Signed, voluntary, informed consent was 
obtained.  
Demographic information was recorded as follows: 
- Race – Four groups: African, Caucasian, Asian and Other. 
- Gender – Female and Male. 
- Age – Three groups: Young Adult (18-39years), Middle Aged (40-59years) and  
  Older Age (60years and older). 
Study numbers were assigned. No personal identification information was recorded for 
study purposes. 
Data was collected during September and October 2015. 
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2.4.1 Inclusion criteria for primary objective (scarred cornea group) 
 
Patients were included if they were 18 years of age or older and had corneal scarring of 
any extent and cause. Corneal pathologies that were occasionally associated with scarring 
and were not considered essential, but that were not excluded were vascularization, 
pigmentation, fibrovascular ingrowth (pannus), elastotic, nodular and other degenerative 
changes, lipid and other deposits.  
Corneal scarring was classified as follows: 
- Aetiology – Four subgroups: Trauma, Inflammatory (including Infective), Other,  
         Combined. 
- Area/Extent – Three subgroups: Central 4mm, Peripheral, Combined. 
 
2.4.2 Exclusion criteria for primary objective (scarred cornea group) 
 
Patients younger than 18 years.  
Refused or unable to give consent.  
Absence of corneal scarring.  
Active keratitis (infective or sterile), corneal abrasions, severe ectatic thinning, perforation 
or full thickness laceration, any other corneal pathology without the presence of corneal 
scarring.  
Phthisis bulbi. 
Contact lens in situ. 
 
2.4.3 Inclusion criteria for control group 
 
18 years or older.  
No corneal pathology.  
No contact lens in situ. 
 
2.4.4 Exclusion criteria for control group 
 
Younger than 18 years. 
Refused or unable to give consent. 
Any corneal abnormality, contact lens in situ, or phthisis bulbi. 
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2.5 Instruments and measurements 
 
2.5.1 Observer 
 
Counselling, consent, examinations and measurements were done by Dr J S Lamprecht 
(JSL), with the help of an ophthalmic assistant or registered nurse. 
 
2.5.2 Instruments 
 
Rebound tonometry measurements were taken using the ICare tonometer (ICare Finland, 
Revenio Group Corporation, Helsinki, Finland). A new probe was used for each 
measurement session. 
Prior to applanation tonometry, the applanation tip was cleaned with a 70% alcohol swab.  
Topical anaesthesia was achieved using Novesin Wander 0.4% (oxybuprocaine HCL, 
Novartis Pharma AG, Adcock Ingram Ltd). 
The tear film was stained using Fluorets 1mg (Bausch & Lomb, Chauvin Pharmaceuticals 
Ltd, UK).  
Applanation tonometry was performed using the Goldmann applanation tonometer (CSO, 
Italy).  
In one patient that was obese and wheelchair-bound, applanation tonometry was performed 
using the Perkins applanation tonometer (Haag-Streit UK). 
If applanation tonometry was found to be impossible (three failed attempts), rebound 
tonometry measurements in that patient would be compared with measurements taken with 
the Tono-Pen XL (Reichert Inc., NY, USA). 
 
2.5.3 Measurement procedure 
 
Calibration was done according to each instrument’s instructions. 
After patients had had their routine assessments, they were referred to the observer, JSL for 
possible inclusion in the study, counselling and consent. 
Measurements were taken in the sequence: RT1, RT2, RT3, GAT1, GAT2, GAT3. 
Where GAT was not possible, TPXL1 – TPXL3 would be taken. 
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Step-by-step: 
1. GAT applanation surface was routinely cleaned with a70% alcohol swab 
A new RT probe was inserted into the RT solenoid. 
2. Anterior segment examination was carried out. The extent of scarring was determined, 
as well as the part of each cornea that was least affected by the scarring process. 
3. Time of RT1 noted. 
4. RT1 – RT3 taken. With the ICare, each measurement actually consists of six 
measurements taken in rapid succession after which the calculated IOP value is digitally 
displayed on the instrument. Care was taken to hold the instrument upright and to hold 
it approximately 4-8mm from the cornea when doing measurements. In each case, 
readings were taken from the area of the cornea that was least affected by the scarring. 
5. GAT1 – GAT3 taken. Each patient’s head and/or eyes were carefully positioned using 
the headrest and fixation target to take measurements from the area of the cornea that 
was least affected by the scarring. 
Each GAT measurement was accepted if all 180˚ of both the mires, including the point 
of intersection between the prism images (representing the stained tear film meniscus), 
were visible and the mire thickness was adequate. Where GAT was not possible. 
TPXL1 – TPXL3 would be taken with a new sleeve. 
6. Time of GAT3 (or TPXL3) noted and time from RT1 to GAT3 calculated. 
 
Following all the measurements, complications were excluded and patients were given an 
opportunity to ask further questions. Follow up appointments were confirmed as per initial 
routine assessments. 
 
The same procedure was followed on both the corneal scar group and the control subjects. 
 
 
2.6 Statistical analysis 
 
Data was captured on Excel spreadsheets (Microsoft), and analysis was done using Excel’s 
built-in formulas as well as GraphPad Instat (GraphPad.com). 
 
For the primary aim of the study, the repeatability of the instruments in patients with 
scarred corneas were determined and compared in the following ways: 
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First, the differences between measurements (within each set of three) were calculated. We 
used the first measure as the reference and compared it to the second and third 
measurements respectively. For each instrument in each group, we looked at the number of 
times that the second and third measurements respectively differed from the first 
measurement by 0mmHg, 1mmHgm 2mmHg and 3mmHg or more and determined the 
range within which the second and third measurements differed from the first. We also 
determined how many measurements had a difference of 2mmHg or more between any 
combination of measurement 1 versus measurements 2 and 3 with RT versus GAT. A 
contingency table was created for each group (one for scarred subjects, one for controls) 
and Fisher’s exact test was used for the significance of the difference between the 
instruments. These calculations and tables were repeated for a difference of 3mmHg or 
more. 
 
Secondly, the data was entered into a non-parametric analysis of variance (ANOVA): The 
Kruskal-Wallis test was used to determine the significance of the difference between 
measurements in each group.  
Finally, the repeatability coefficient (CR) was calculated for each instrument in each group 
of patients, using the formula: 
 
  (1.96 × √2×𝑤𝑠SD)57  where wsSD is the within-subject standard deviation. 
 
In other words, two repeatability studies were carried out at the same time, one with RT 
and one with GAT respectively on the scarred subjects. The CR is an estimate of the 
absolute difference, or disagreement, between measurements caused by measurement 
errors only. It is based on the assumption that there is no bias or learning between 
measurements. The estimate is given in the unit of measurement, in the case of this study, 
mmHg. Only the first two measurements of each series of three measurements were used 
(i.e. RT1 and RT2, GAT1 and GAT2). If the differences between two measurements made 
on a subject are normally distributed, we expect the absolute difference between the two 
measurements on a subject to differ by no more than the repeatability coefficient on 95% 
of occasion. By plotting the differences between measurements against their mean values 
(the Bland-Altman plot), we could also visually assess and compare the disagreements 
between measurements for each instrument.57 
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As secondary objective, we also compared the repeatability of RT with that of GAT in a 
control population. Furthermore, we did a comparison between RT and GAT in terms of 
the correlation of their IOP estimates. Although the latter correlation is described at length 
in the Literature Review, any difference in terms of repeatability would be of doubtful 
significance if the instruments were not once again shown to correlate well with each other 
in this study population. 
 
For each set of three measurements (e.g. RT1 – RT3), the individual mean IOP was 
calculated. For each instrument, the overall mean IOP (the mean of the means) was 
calculated. We did a comparison of the individual and overall mean IOPs for RT versus 
GAT to determine correlation and to see whether RT overestimated or underestimated 
GAT IOP. We used the correlation coefficient (r) to test the significance of the correlation. 
We also calculated the number of eyes in which RT overestimated versus underestimated 
GAT. We used Fisher’s exact test on the whole group excluding those that measured the 
same to determine whether the difference was significant. 
 
Subgroup analyses, for example testing for correlations between repeatability on the one 
side and extent of scarring, cause of scarring, total measurement time, etc. on the other 
side, were not done due to sample size. Should this study be extended, these could be 
considered. 
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3 RESULTS 
 
Tables 3.1 and 3.2 summarize the population characteristics of the scarred subjects and 
controls respectively.  
 
In the scarred group, 61 eyes of 48 patients were included. Racial distribution was as 
follows: African 59 eyes (96.7%), Caucasian 1 eye (1.6%), Asian 0 (0%) and other 1eye 
(1.6%). There were 33 eyes (54.1%) in female patients and 28 eyes (45.9%) in male 
patients in the scarred group. Age groups consisted of 28 young adult eyes (45.9%), 18 
middle aged eyes (29.5%) and 15 older age eyes (24.6%). The cause of corneal  scarring 
was trauma in 12 eyes (19.7%), inflammatory in 27 eyes (44.3%), other in 14 eyes (22.9%) 
and combined in 8 eyes (13.1%). The scarring involved only the central 4mm of the cornea 
in 8 eyes (13.1%), the peripheral cornea in 12 eyes (19.7%), and combined in 41 eyes 
(67.2%). 
 
Controls were not matched with the scarred group for age, gender or ethnicity. 61 eyes of 
31 patients were included. Racial distribution (for eyes, not patients) was 41 African 
(67.2%), 10 Caucasian (16.4%), 8 Asian (13.1%) and 2 other (3.3%). 48 eyes (78.7%) 
belonged to female patients and 13 eyes (21.3%) to male patients. Young adult eyes 
numbered 24 (39.3%), middle aged 22 (33.1%) and older age 15 (24.6%). 
 
Figures 3.1 and 3.2 represent the differences between measurements in the scarred and 
control groups respectively. In each patient, RT1 was compared to RT2 and RT3 
respectively and GAT1 was compared to GAT2 and GAT3 respectively.  
 
In the scarred corneas, for RT1 vs RT2, there was no difference in 17 eyes, 1mmHg 
difference in 19 eyes, 2mmHg difference in 16 eyes and 3mmHg or more difference in 9 
eyes. For RT1 vs RT3, there was no difference in 20 eyes, 1mmHg difference in 18 eyes, 
2mmHg difference in 8 eyes and 3mmHg or more difference in 15 eyes. 
In the scarred corneas, for GAT1 vs GAT2, there was no difference in 6 eyes, 1mmHg 
difference in 13 eyes, 2mmHg difference in 21 eyes and 3mmHg or more difference in 21 
eyes. For GAT1 vs GAT3, there was no difference in 14 eyes, 1mmHg difference in 19 
eyes, 2mmHg difference in 12 eyes and 3mmHg or more difference in 16 eyes. 
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Table 3.1 – Study population: Scarred corneas 
Scarred Subjects n = 61 (%) 
 
Race:  
- African 
- Caucasian 1  
- Asian 
- Other 
 
Gender:  
- Female 
- Male 
 
Age:  
- Young Adults 
- Middle Aged 
- Older Age 
 
Aetiology: 
- Trauma 
- Inflammatory 
- Other 
- Combined 
 
Area Involved:  
- Central 
- Peripheral 
- Central and Peripheral 
 
 
 
59 
1 
0 
1 
 
 
33 
28 
 
 
28 
18 
15 
 
 
12 
27 
14 
8 
 
 
8 
12 
41 
 
 
(96.7%) 
(1.6%) 
 
(1.6%) 
 
 
(54.1%) 
(45.9%) 
 
 
(45.9%) 
(29.5%) 
(24.6%) 
 
 
(19.7%) 
(44.3%) 
(22.9%) 
(13.1%) 
 
 
(13.1%) 
(19.7%) 
(67.2%) 
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Table 3.2 – Study population: Controls 
Controls n = 61  
 
Race:  
- African 
- Caucasian 
- Asian 
- Other 
 
Gender:  
- Female 
- Male 
 
Age:  
- Young Adults 
- Middle Aged 
- Older Age 
 
 
 
41 
10 
8 
2 
 
 
48 
13 
 
 
24 
22 
15  
 
 
(67.2%) 
(16.4%) 
(13.1%) 
(3.3%) 
 
 
(78.7%) 
(21.3%) 
 
 
(39.3%) 
(33.1%) 
(24.6%) 
 
 
In the control corneas, for RT1 vs RT2, there was no difference in 23 eyes, 1mmHg 
difference in 28 eyes, 2mmHg difference in 8 eyes and 3mmHg or more difference in 2 
eyes. For RT1 vs RT3, there was no difference in 17 eyes, 1mmHg difference in 22 eyes, 
2mmHg difference in 14 eyes and 3mmHg or more difference in 8 eyes. 
In the control corneas, for GAT1 vs GAT2, there was no difference in 34 eyes, 1mmHg 
difference in 21 eyes, 2mmHg difference in 5 eyes and 3mmHg or more difference in 1 
eye. For GAT1 vs GAT3, there was no difference in 26 eyes, 1mmHg difference in 25 
eyes, 2mmHg difference in 10 eyes and 3mmHg or more difference in no eyes. 
 
Table 3.3 shows the number of eyes in which repeat measurements differed by 2mmHg 
and more, and by 3mmHg and more, as well as the range of the differences. 
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Figure 3.1 – Differences in measures: Scarred subjects 
 
 
 
Figure 3.2 – Differences in measures: Controls 
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Table 3.3 – Difference in measures: 2mmHg or more, 3mmHg or more, and range 
Scars  n Difference of 
2mmHg or 
more 
n Difference of 
3mmHg or 
more 
Range 
RT1 vs RT2 25 9 -5 to +5 
RT3 23 15 -5 to +5 
GAT1 vs Gat2 42 21 -9 to +13 
Gat3 28 16 -5 to +19 
 
Controls 
 
    
RT1 vs RT2 10 2 -2 to +3 
RT3 22 8 -4 to +5 
GAT1 vs Gat2 6 1 -2 to +3 
Gat3 10 0 -2 to +2 
 
 
The data for differences of 2mmHg or more between either combination of measurements 
(1st vs 2nd and 1st vs 3rd) and for RT vs GAT, shows that RT was significantly more 
reliable than GAT in the group with scarred corneas (Fisher’s exact test: p = 0.0218). 32 
combinations with RT and 45 combinations with GAT had differences of 2mmHg or more. 
16 patients for RT and 24 patients for GAT had both 2nd and 3rd measures 2mmHg or more 
different from measure 1. 
In the control group, GAT was significantly more reliable than RT (Fisher’s exact test:  p = 
0.0014). 27 combinations with RT and 10 combinations with GAT had differences of 
2mmHg or more. 5 patients for RT and 6 patients for GAT had both 2nd and 3rd measures 
2mmHg or more different from measure 1. 
Repeating these calculations for differences between measurements of 3mmHg or more, 
showed that RT was no longer significantly more reliable than GAT in the scarred group 
(Fisher’s exact: p = 0.4416) and that GAT was still significantly better than RT in the 
control group (Fisher’s exact: 0.0166).   
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Kruskal-Wallis test on the differences between repeat measurements showed that there was 
one set of measurements in the scarred group where the differences were significantly 
different, namely between either combination with RT and the first repeat of GAT (p < 
0.01). Differences between GAT 1 and 3 and either combination of RT did not reach 
statistical significance. Overall, the difference between differences were significant in the 
scarred group (p = 0.0006), but not in the control group (p = 0.6738). 
Analysis of the raw data showed that, overall, neither of the instruments obtained 
significantly different values with repeat measurements in either population. The 
significance of the differences were as follows (Kruskal-Wallis): 
 
Scarred Corneas: RT p = 0.9259 
   GAT  p = 0.4902 
Controls:  RT p = 0.9536 
   GAT p = 0.9910 
 
The results of the repeatability coefficient studies are presented in table 3.4. In the scarred 
group, repeatability was better with RT than with GAT, with estimated measurements 
errors of 2.667mmHg and 4.819mmHg respectively. In the control group, GAT was better 
than RT, both with estimated measurement errors of less than 2mmHg and that of GAT 
being only 1.092mmHg. 
 
Table 3.4 – Repeatability coefficients of RT and GAT in scarred corneas and controls 
Group: Instrument: Repeatability coefficient (CR) 
Scarred corneas 
 
RT 
GAT 
2.667mmHg 
4.819mmHg 
Controls 
 
RT 
GAT 
1.607mmHg 
1.092mmHg 
 
 
Bland-Altman plots of the differences between repeat measurements for each instrument in 
each subgroup are seen in figures 3.3, 3.4, 3.5 and 3.6. Plotted values represent the size of 
measurement errors (vertical axis) at a range of mean IOPs (horizontal axis). Data points 
that are in general grouped more closely around the horizontal line through the vertical 
midpoint (the zero difference line) indicate greater repeatability, and vice versa.  
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In figures 3.3 and 3.4 it can be seen that data points representing RT measurement error are 
less widely distributed around the zero difference line than those for GAT, indicating 
greater repeatability of RT in patients with scarred corneas. Figures 3.5 and 3.6 represent 
the measurement errors of RT and GAT respectively in the control population. Both 
instruments show good repeatability in this subgroup of patients with data point lying close 
to the zero difference line.  
 
 
Figure 3.3  –  RT repeatability at different IOPs in scarred corneas 
  (Bland-Altman plot) 
 
 
Figure 3.4  –  GAT repeatability at different IOPs in scarred corneas 
  (Bland-Altman plot) 
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Figure 3.5  –  RT repeatability at different IOPs in normal corneas 
  (Bland-Altman plot) 
 
 
Figure 3.6  –  GAT repeatability at different IOPs in normal corneas 
  (Bland-Altman plot) 
 
 
Our method comparison study showed good correlation between RT and GAT in both 
study subgroups. The individual means of RT and GAT are plotted against each other in 
figure 3.7 for patients with corneal scars and figure 3.8 for the controls. The difference 
between the individual mean IOPs of RT vs GAT are plotted against the mean IOP in 
figure 3.9 for the scarred subjects and figure 3.10 for the controls. 
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Figure 3.7 – Correlation of RT vs GAT – Individual means: Scarred subjects 
 
 
Figure 3.8 – Correlation of RT vs GAT – Individual means: Controls 
 
 
The correlation coefficient for individual means of RT vs GAT in the two study subgroups 
were as follows: 
 
Scarred Corneas: r = 0.8959; p< 0.0001  
 
Controls:  r = 0.8298; p< 0.0001 
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Figure 3.9 – Differences between RT and GAT – Individual means: Scars 
 
 
Figure 3.10 – Differences between RT and GAT – Individual means: Controls 
 
In the scarred group, the overall mean IOP with RT was 14.2mmHg (with an overall mean 
standard deviation of 0.8) and the overall mean IOP with GAT was 13.6mmHg (overall 
mean SD of 1.4). RT therefore produced a mean IOP estimation in the scarred subjects that 
was 0.6mmHg higher than that of GAT. 
In the controls, the overall mean IOP with RT was 14.1mmHg (with an overall mean 
standard deviation of 0.7) and the overall mean IOP with GAT was 12.6mmHg (overall 
mean SD of 0.4). RT therefore produced a mean IOP estimation in the controls that was 
1.5mmHg higher than that of GAT. 
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In both figures 3.9 and 3.10 the distribution of data points are skewed towards the positive 
side. These plots represent the values of RT minus GAT (and not GAT minus RT) and 
therefore also indicate higher IOPs obtained with RT than with GAT. In the scarred group, 
RT obtained individual mean IOPs that were higher than GAT in 31 eyes, lower than GAT 
in 28 eyes, and the same in 2 eyes. In the control group, RT obtained individual mean IOPs 
that were higher than GAT in 37 eyes and lower than GAT in 24 eyes. Fisher’s exact test 
on the whole group excluding those that measured the same gave a p-value of 0.4614, 
showing again that the difference between the instruments were not significant. 
 
Time elapsed between RT1 and GAT3 in the scarred population was a mean of 12minutes 
and 44seconds. 
Time elapsed between RT1 and GAT3 in the control population was a mean of 37minutes 
and 13seconds. 
 
There was no need for the Tono-Pen XL to be used in this study. By carefully selecting the 
area of the cornea from which measurements were to be taken, and by positioning the 
patient’s head and eyes with the help of the headrest and fixation target, we managed to get 
acceptable GAT measurements in all patients.  
 
No complications were caused by the study procedure during the entire course of the study. 
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4 DISCUSSION 
 
In this study we set out to directly compare the reliability of rebound tonometry (RT) with 
the reliability of Goldmann applanation tonometry (GAT) in patients with corneal 
pathology. In our study we specified the type of corneal pathology, namely corneal scars. 
With corneal pathology being known to cause unreliable GAT measurements,13,14,15,16,17,18 
our main was not to test the correlation of RT with GAT in terms of their IOP 
measurements, but rather to determine the repeatability or inversely, test-retest variability 
with both instruments in the same population at the same time. 
 
RT has been shown to have good intraobserver and interobserver correlation coefficients in 
normal eyes, ranging between 0.46 and 0.96 (intraobserver) and between 0.62 and 0.92 
(interobserver).29 The repeatability coefficient was not used in this particular series and no 
direct comparison was made with the correlation coefficients of GAT in the same patients. 
In another study, the test-retest repeatability was assessed using values taken two weeks 
apart.40 RT was directly compared with GAT in the same population. Bland-Altman plots 
were also used to show differences between measurements and the repeatability was 
expressed in terms of 95% limits of agreement. The limits of agreement between repeated 
measurements were ±5.11mmHg for RT and ±3.15mmHg for GAT. One could argue 
against the relevance of this comparison due to the dynamic, fluctuating nature of IOP and 
therefore the likely difference between measurements taken two weeks apart, but 
considering that GAT is the proven gold standard and that this study was done on normal 
eyes, one would accept that the results reflect a true comparison between the repeatability 
of the two instruments. 
 
In our study, repeat measurements were taken seconds to minutes after one another and 
followed within minutes by the repeat GAT measurements to try and achieve a relevant 
comparison. We also did multiple different analyses of the difference between 
measurements to determine whether findings were statistically consistent and significant. 
The first measurement was used as the reference and compared to the second and third 
measurements respectively. In clinical practice, one would preferably do only one 
measurement. The repeatability of the first measurement is therefore the most important. A 
difference between measurements of 2mmHg or more was used as a clinically significant 
cut-off, but we also looked at smaller and larger differences. All analyses showed RT to 
31 
 
have less test-retest variability and therefore greater reliability than GAT in patients with 
corneal scars, with most tests reaching statistical significance.  
 
Basic analysis of the difference between repeat measurements showed that RT had the 
highest number of “no difference” between measurements and the lowest number of 
“2mmHg or more” and “3mmHg or more” difference between measurements in patients 
with corneal scars. The range of difference between repeat measurements was also lower 
with RT than with GAT in the scarred population (Table 3.3). Using Fisher’s Exact test on 
the measurement series that had differences of 2mmHg or more showed that RT was 
significantly more reliable than GAT in patients with corneal scars. Interestingly, when 
using the same test for differences of 3mmHg or more, RT was still more reliable, but not 
statistically significantly so. This finding can be interpreted in different ways, one being 
that, although RT performed better than GAT when using a difference of 2mmHg as cut-
off, GAT was not far behind in terms of reliability in these patients. 
 
Analysis of variance (ANOVA) is a way of testing differences between more than two 
groups. The Kruskal-Wallis test is an ANOVA used on non-parametric data. In our study 
we had three groups of IOP values for each instrument in each patient, as well as two 
groups of differences between measurements for each instrument in each patient. Kruskal-
Wallis test on the raw data showed that difference between measurements were not 
statistically significant. This supports previous findings that GAT is still clinically relevant 
for measuring IOP in patients with corneal pathology despite its known limitations.26,43 
However, the difference between differences were highly significant for either 
combination or RT compared the difference between GAT1 and GAT2. Interestingly, the 
difference between GAT1 and GAT3 compared to the difference between either 
combination of RT did not reach statistical significance, and we cannot explain why this is 
the case.  
 
The third way in which we compared the reliability of the instruments was by calculating 
the repeatability coefficient (CR) of each instrument in each subgroup. The usefulness of 
this measure is that it represents an estimation of the absolute measurement error in the 
unit of the original measurement.57 For example, in our study and in the scarred subgroup, 
RT had a CR of 2.667. This means that one would expect the absolute difference between 
repeat measurements with RT on subjects with corneal scars to differ by no more than 
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2.667mmHg on 95% of occasions.57 The CR of GAT in the scarred patients was 4.819. RT 
therefore once again showed greater repeatability than GAT in patients with corneal scars.  
As mentioned in the Results section, the Bland-Altman plots in figure 3.3 and figure 3.4 
give a visual representation of the differences between the repeatability of the instruments.  
 
We also tested the correlation of mean IOP with RT versus GAT in our study population. 
If RT was found to greatly over- or underestimate GAT IOP, or not correlate with GAT at 
all, any advantage in terms of repeatability would be of little clinical relevance.  
Most studies report excellent correlation and good agreement of RT with GAT, with a 
mean difference between IOP estimates of 1mmHg or less.19,21,23,27,28,30,34,40,41 In all but one 
of these studies RT overestimated GAT IOP.21 A reduced agreement between the two 
instruments have also been reported, the worst being a mean overestimation of 6.5mmHg 
in patients with oedematous corneal grafts. In most instances, the patient population in 
these studies had some form anterior segment abnormality, either structural or in the form 
of raised IOP.22,23,24,25,29,54,55 Again, in all but one study RT overestimated GAT IOP.54  
Our study revealed excellent correlation of RT with GAT (r = 0.8959; p< 0.0001) and 
excellent agreement, with RT overestimating GAT IOP by a mean of 0.6mmHg. This 
finding was more in keeping with previous correlation studies done with normal corneas, 
despite the fact that our study population had abnormal corneas. We did not specifically 
select patients with a wide range of IOPs to test the correlation across this range. 
 
In our control subjects (absence of corneal pathology), GAT performed better than RT in 
terms of repeatability and reliability. In figure 3.2 it can be seen that GAT had the highest 
number of “no difference” between repeat measurements and the lowest number of 
“3mmHg or more” difference between measurements. The range of differences between 
measurements was also lower with GAT than with RT. ANOVA showed excellent 
repeatability with both instruments, but when looking at the measurement series with 
differences of 2mmHg or more, GAT was significantly more reliable in the control 
population (p = 0.0014). The repeatability coefficient of GAT was also better than RT’s. 
The correlation of RT with GAT in the control population was excellent (r = 0.8298; p< 
0.0001) and agreement was similar to that found in previous reports, with RT 
overestimating GAT IOP by a mean of 1.5mmHg. Our findings in the control population 
support the continued use of Goldmann applanation tonometry as the gold standard for IOP 
measurement in patients with normal corneas. 
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The time elapsed between RT1 and GAT3 was different for the scarred group versus the 
controls. This time represented mainly the time between RT3 and GAT1, and was different 
for the two groups due to the different days on which patients were recruited. Scarred 
subjects were recruited throughout the week whereas controls were mainly recruited on 
two consecutive Fridays. The dynamics of the out-patient department with its different 
subspecialty clinics on different days of the week inherently influenced the types and 
numbers of corneal pathologies seen on each day as well as the availability of a slit lamp 
for examining the study subjects and controls. Despite the longer waiting period between 
RT and GAT in the control group, there was only a slight reduction in correlation and 
agreement between the two instruments which was not statistically significant. 
One also needs to consider the possibility of learning, that is, bias caused by taking repeat 
measurements in too rapid succession. However, we considered the relatively short interval 
between repeat measurements to be the best way to estimate the true repeatability. The bias 
caused by learning is reduced by instruments such as RT and Tono-Pen XL that give an 
objective, digital reading, as opposed to instruments which have an analogue scale that 
needs to be fine-tuned by the observer, as is the case with most Goldmann applanation 
tonometers. 
 
A more useful measure of time would have been comparing the time taken from RT1 to 
RT3 with that of GAT1 to GAT3. Although not formally tested, it is the author’s 
experience that RT was faster and easier to use than GAT.  
 
It is important to note that we did not match the controls with the scarred subjects in terms 
of race, gender or age. Another way of stating the purpose of the study is that we 
determined the effect of corneal scarring on the repeatability of measurements with two 
different instruments. The main purpose of the control group was therefore not to compare 
results in scarred versus normal corneas, but to demonstrate observer proficiency at both 
measurement techniques so as to strengthen the significance of any findings in the scarred 
group. Baseline repeatability, correlation and agreement were expected to be good and 
comparable with previous reports in this particular population and setting, and this was 
found to be the case. Basic demographic data were recorded as part of routine study 
procedure and for the purpose of possible future study extensions or comparisons, but 
subgroup analyses were not done due to sample size and time restrictions. We do not 
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expect these variables to have a major effect on the outcomes of our study; however, this 
cannot be concluded without being formally tested. 
 
The Tono-Pen XL was tested before measurement sessions, and as reported in the 
literature47 multiple recalibrations had to be done, sometimes consecutively, before the 
instrument was ready for use. In one study directly comparing GAT, RT and Tono-Pen 
with each other, RT was shown to correlate better with GAT than Tono-Pen.19 In another 
report, RT and Tono-Pen was shown to be more accurate than GAT over a wide range of 
IOPs in oedematously thickened corneas.42 There was no need to use the Tono-Pen XL in 
our study. By carefully selecting the area of the cornea from which measurements were to 
be taken, and by positioning each patient’s head and eyes with the help of the headrest and 
fixation target, we managed to achieve GAT measurements in all patients. GAT 
measurements were considered acceptable if all 180˚ of both the mires, including the point 
of intersection between the prism images, were visible and the mire thickness was 
appropriate. ANOVA of differences between GAT1, 2 and 3 showed that differences were 
not statistically significant (Kruskal-Wallis, p = 0.4902). This is in keeping with previous 
findings that GAT is still clinically relevant for measuring IOP in patients with corneal 
pathology despite its known limitations.26,43 On the other hand, the CR of GAT in the 
scarred population was 4.819, which means that one can expect the absolute difference 
between repeat measurements with GAT in patients with corneal scars to be no more than 
4.819mmHg on 95% of occasions.57 This would be considered too high a measurement 
error by many and supports the opinion that GAT is not clinically relevant in patients with 
corneal pathology. 13,14,15,16,17,18,51 We acknowledge that there are circumstances in which 
GAT would not be possible at all, but this was not the case in the consecutive patients seen 
during our study. Correlations with extent and cause of corneal scarring were not done due 
to sample size. Greater extent of scarring and certain other causes of severe ocular surface 
irregularity, such as diffuse bullous keratopathy and chronic cicatrizing conjunctivitis 
might render GAT useless, in which case the clinical relevance of RT might be even 
greater and it would need to be compared to other instruments such as the Tono-Pen XL. 
Including more patients and a wider range of corneal pathologies could give a better 
indication of the clinical usefulness of each instrument in specific situations. 
 
Finally, although repeatability is an important measure of an instrument’s reliabi lity, the 
only way of truly knowing which tonometer is more accurate would be to compare it to 
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manometric (true) IOP. RT and Tono-Pen XL have been shown to be more accurate than 
GAT in oedematously thickened corneas when compared to manometric pressures.42 
 
 
4.1 Conclusion 
 
In patients with corneal scars, rebound tonometry (RT) was found to be more reliable than 
Goldmann applanation tonometry (GAT) on the basis of its greater repeatability. This, 
along with the good correlation found between RT and GAT, makes RT the ideal 
measurement tool for IOP in these patients. Our findings support the continued use of GAT 
as the gold standard for IOP measurement in patients with normal corneas. However, RT 
correlated well with GAT and showed good reliability in patients with normal corneas, 
which, together with its ease of use, make it a viable option to use as screening tool and in 
patients in whom GAT might not be possible for reasons other than corneal pathology.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
36 
 
REFERENCES  
 
1. Resnikoff S, Pascolini D, Etya’ale D, et al. Global data on visual impairment in the 
year 2002. Bulletin WHO 2002;82:844-851 
2. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 
and 2020. Br J Ophthalmol 2006;90:262-267 
3. Rotchford AP, Johnson GJ. Glaucoma in Zulus: A population-based cross-sectional 
survey in a rural district in South Africa.  Arch Ophthalmol 2002;120:471-478 
4. Rotchford AP, Kirwin JF, Muller MA, et al. Temba glaucoma study: A population-
based cross-sectional survey in urban South Africa. Ophthalmology 2003;110:376-
382 
5. Cook C. Glaucoma in Africa: Size of the problem and possible solutions. J 
Glaucoma 2009;18:124-128 
6. Agarwal R, Gupta SK, Agarwal P, et al. Current concepts in the pathophysiology of 
glaucoma. Indian J Ophthalmol 2009;57:257-266 
7. Gordon MO, Beiser JA, Brandt JD, et al. The ocular hypertension treatment study: 
Baseline factors that predict the onset of primary open-angle glaucoma. Arch 
Ophthalmol 2002;120:714-720 
8. Leske MC, Heijl A, Hussein M, et al. Factors for glaucoma progression and the effect 
of treatment – The early manifest glaucoma trial. Arch Ophthalmol 2003;121:48-56 
9. Kass MA, Heuer DK, Higginbotham EJ, et al. The ocular hypertension treatment 
study: A randomized trial determines that topical ocular hypotensive medication 
delays the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120:701-
713 
10. Collaborative Normal-tension Study Report II. The effectiveness of intraocular 
pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol 
1998;126:498-505 
11. Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and 
glaucoma progression – Results from the Early manifest glaucoma trial. Arch 
Ophthalmol 2002;120:1268-1279 
12. The AGIS Investigators. AGIS report 7: The relationship between control of 
intraocular pressure and visual field deterioration. Am J Ophthalmol 2000;130:429-
440 
37 
 
13. Whitacre MM, Stein R. Sources of error with use of Goldmann-type tonometers. 
Surv Ophthalmol 1993;38:1-30 
14. Damji KF, Muni RH, Munger RM. Influence of corneal variables on accuracy of 
intraocular pressure measurement. J Glaucoma 2003;12:69-80 
15. Hamilton KE, Pye DC, Hali A, et al. The effect of contact lens induced corneal edema 
on Goldmann applanation tonometry measurements. J Glaucoma 2007;16:153-158 
16. Chihara E. Assessment of true intraocular pressure: The gap between theory and 
practical data. Surv Ophthalmol 2008;53:203-218 
17. Kniestedt C, Punjabi O, Lin S, et al. Tonometry through the ages. Surv Ophthalmol 
2008;53:568-591 
18. Rosentreter A, Athanasopoulos A, Schild AM, et al. Rebound, Applanation, and 
Dynamic Contour Tonometry in Pathologic Corneas. Cornea 2013;32:313-318 
19. Van der Jagt LH, Jansonius NM. Three portable tonometers, the TGDc-01, the ICare 
and the Tonopen XL, compared with each other and the Goldmann applanation 
tonometry. Ophthal Physiol Opt 2005;25:429-435 
20. Gonzalez-Meijome JM, Jorge J, Queiros A, et al. Age differences in central and 
peripheral intraocular pressure using a rebound tonometer. Br J Ophthalmol 
2006;90:1495-1500 
21. Abraham LM, Epasinghe NCR, Selva D, et al. Comparison of the ICare rebound 
tonometer with the Goldmann applanation tonometer by experienced and 
inexperienced tonometrists. Eye 2008;22:503-506 
22. Martinez-de-la-Casa JM, Garcia-Feijoo J, Saenz-Frances F, et al. Comparison of 
rebound tonometer and Goldmann handheld applanation tonometer in congenital 
glaucoma. J Glaucoma 2009;18:49-52 
23. Marini M, Da Pozzo S, Accardo A, et al. Comparing applanation tonometry and 
rebound tonometry in glaucomatous and ocular hypertensive eyes. Eur J 
Ophthalmol 2011;21:258-263 
24. Li Y, Tang L, Xiao M, et al. Comparison of the ICare tonometer and the hand-held 
Goldmann applanation tonometer in paediatric aphakia. J Glaucoma 2013;22:550-
554 
25. Suman S, Agrawal A, Pal VK, et al. Rebound Tonometer: Ideal Tonometer for 
Measurement of Accurate Intraocular Pressure. J Glaucoma 2014;23:633-637 
38 
 
26. Fabian ID, Barequet IS, Skaat A, et al. Intraocular Pressure Measurements and 
Biomechanical Properties of the Cornea in Eye After Penetrating Keratoplasty. 
Am J Ophthalmol 2011;151:774-781 
27. Parkou N, Gray T, Mills R, et al. Clinical Comparison of the ICare Tonometer and 
Goldmann Applanation Tonometry. J Glaucoma 2008;17:43-47 
28. Moreno-Montañes J, Martinez-de-la-Casa JM, Sabater AL, et al. Clinical Evaluation 
of the New Rebound Tonometers ICare Pro and ICare ONE Compared with the 
Goldmann Tonometer. J Glaucoma 2014;00:1-6 
29. Martinez-de-la-Casa JM, Garcia-Feijoo J, Castillo A, et al. Reproducibility and 
clinical evaluation of rebound tonometry. Inv Ophthalmol Vis Sci 2005;46:4578-4580 
30. Iliev ME, Goldblum D, Katsoulis K, et al. Comparison of rebound tonometry with 
Goldmann applanation tonometry and correlation with central corneal thickness. 
Br J Ophthalmol 2006;90:833-835 
31. Shimazaki J, Amano S, Uno T, et al. National Survey on Bullous Keratopathy in 
Japan. Cornea 2007;26:274-278 
32. Fukuoka S, Honda N, Usui T, et al. Penetrating keratoplasty for bullous keratopathy 
after trabeculectomy. Eye 2009;23:940-944 
33. Al-Mahmood AM, Al-Swailem SA, Edward DP. Glaucoma and corneal transplant 
procedures. J Ophthalmol 2012;2012:1-9 
34. Moreno-Montañes J, Garcia N, Fernandez-Hortelano A, et al. Rebound Tonometer 
Compared With Goldmann Tonometer in Normal and Pathologic Corneas. Cornea 
2007;26:427-430 
35. Aldave AJ, King JA, Cunningham ET. Ocular Syphilis. Curr Opin Ophthalmol 
2001;12:433-441 
36. Sungur GK, Hozirolan D, Yalvac IS, et al. Incidence and prognosis of ocular 
hypertension secondary to viral uveitis. Int Ophthalmol 2010;30:191-194 
37. Idrees F, Vaideanu D, Fraser S, et al. A review of anterior segment dysgeneses. Surv 
Ophthalmol 2006;51:213-231 
38. Girkin CA, McGwin G, Long C, et al. Glaucoma after ocular contusion: A cohort 
study of the United States Eye Injury Registry. J Glaucoma 2005;14:470-473 
39. Girkin CA, McGwin G, Morris R, et al. Glaucoma following penetrating ocular 
trauma: A cohort study of the United States Eye Injury Registry. Am J Ophthalmol 
2004;139:100-105 
39 
 
40. Davies LN, Bartlett H, Mallen EAH, et al. Clinical evaluation of rebound tonometer. 
Acta Ophthalmol Scand 2006;84:206-209 
41. Jablonski KS, Rosentreter A, Gaki S, et al. Clinical use of a new position-independent 
rebound tonometer. J Glaucoma 2013;22:763-767 
42. Neuburger M, Maier P, Böhringer D, et al. The Impact of Corneal Edema on 
Intraocular Pressure Measurement Using Goldmann Applanation Tonometry, 
Tono-Pen XL, iCare, and ORA: An In Vitro Model. J Glaucoma 2013;22:584-590 
43. Arribas-Pardo P, Mendez-Hernandez C, Cuiña-Sardiña R, et al. Measuring 
Intraocular Pressure After Intrastromal Corneal Ring Segment Implantation 
With Rebound Tonometry and Goldmann Applanation Tonometry. Cornea 
2015;34:516-520 
44. Von Spiessen L, Karck J, Rohn K, et al. Clinical comparison of the TonoVet rebound 
tonometer and the Tono-Pen Vet applanation tonometer in dogs and cats with 
ocular disease: glaucoma or corneal pathology. Vet Ophthalmol 2013;18:20-27 
45. Browning AC, Bhan A, Rotchford AP, et al. The effect of corneal thickness on 
intraocular pressure measurement in patients with corneal pathology. Br J 
Ophthalmol 2004;88:1395-1399 
46. Tonnu PA, Ho T, Newson T, et al. The influence of central corneal thickness and age 
on intraocular pressure measured by pneumotonometry, non-contact tonometry, 
the Tono-Pen XL, and Goldmann applanation tonometry. Br J Ophthalmol 
2005;89:851-854 
47. Iester M, Mermoud A, Achache F, et al. New Tono-Pen XL: comparison with the 
Goldmann tonometer. Eye 2001;15:52-58 
48. Goldmann, H. A new applanation tonometer. Bull Soc Franc Ophthal 1954;67:474-
478 [Abstract - Full article originally in French.] 
49. Gloster J, Perkins ES, Jackson CRS. Discussion: Tonometry. Proceed Royal Soc Med 
1957;50:667-676 
50. Perkins ES. Hand-held applanation tonometer. Br J Ophthalmol 1965;49:591 
51. Kaufman HE. Pressure measurement: Which tonometer? Inv Ophthalmol 
1972;11:80-85 
52. Kontiola A. A new electromechanical method for measuring intraocular pressure. 
Doc Ophthalmol 1997;93:265-276 
40 
 
53. Fernandes P, Diaz-Rey JA, Queiros A, et al. Comparison of the ICare rebound 
tonometer with the Goldmann tonometer in normal population. Ophthal Physiol 
Opt 2005;25:436-440 
54. Salvetat ML, Zeppieri M, Miani F, et al.  Comparison of iCare tonometer and 
Goldmann applanation tonometry in normal corneas and in eyes with automated 
lamellar and penetrating keratoplasty. Eye 2011;25:642-650 
55. Chui WS, Lam A, Chen D, et al. The Influence of Corneal Properties on Rebound 
Tonometry. Ophthalmology 2008;115:80-84 
56. Grigorian F, Grigorian AP, Olitsky SE. The use of the ICare tonometer reduced the 
need for anaesthesia to measure intraocular pressure in children. Journal of AAPOS 
2012;16:508-510 
57. Bartlett JW, Frost C. Reliability, repeatability and reproducibility: analysis of 
measurement errors in continuous variables. Ultrasound Obstet Gynecol 
2008;31:466-475 
